Magnetic Resonance in Experimental and Clinical Oncology: Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989
Over the past decade, techniques have been developed and implemented to observe metabolism noninvasively in localized regions of intact, living experimental animals and humans through the use of magnetic resonance spectroscopy (MRS). At the same time, magnetic resonance imaging (MRI) techniques deve...
Gespeichert in:
| Weitere Verfasser: | , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
Springer US
1990
|
| Schriftenreihe: | Developments in Oncology
61 |
| Schlagworte: | |
| Online-Zugang: | UBR01 URL des Erstveröffentlichers |
| Zusammenfassung: | Over the past decade, techniques have been developed and implemented to observe metabolism noninvasively in localized regions of intact, living experimental animals and humans through the use of magnetic resonance spectroscopy (MRS). At the same time, magnetic resonance imaging (MRI) techniques developed in the 1970s and refined in this decade have been increasingly applied as a powerful clinical tool to probe human anatomy. Because of the unusual metabolic and physiologic characteristics of malignant tissues, oncology has been one of the primary focuses of the application of both MRS and MRI. Although considerable progress has been made in oncologic applications of magnetic resonance (MR), further research is needed to realize the full potential of MR in this area. Consequently, the 21st Annual Detroit Cancer Symposium entitled "Magnetic Resonance in Experimental and Clin ical Oncology" was organized to provide a forum for researchers in the field to report the state of the art of MRS and MRI in oncol ogy, to discuss future goals for MRS and MRI in oncology, and to define the research needed to meet those goals. The major emphasis of the symposium was on MRS due to both the recent widespread availability of clinical MRS instrumentation and the extensive amount of animal MRS research performed over the past half decade |
| Beschreibung: | 1 Online-Ressource (XVI, 392 p) |
| ISBN: | 9781461306917 |
| DOI: | 10.1007/978-1-4613-0691-7 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046145602 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1990 |||| o||u| ||||||eng d | ||
| 020 | |a 9781461306917 |9 978-1-4613-0691-7 | ||
| 024 | 7 | |a 10.1007/978-1-4613-0691-7 |2 doi | |
| 035 | |a (ZDB-2-SME)978-1-4613-0691-7 | ||
| 035 | |a (OCoLC)1119038745 | ||
| 035 | |a (DE-599)BVBBV046145602 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.994 |2 23 | |
| 245 | 1 | 0 | |a Magnetic Resonance in Experimental and Clinical Oncology |b Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989 |c edited by Jeffrey L. Evelhoch, William Negendank, Frederick A. Valeriote, Laurence H. Baker |
| 246 | 1 | 3 | |a Proceedings of the 21st Annual Detroit Cancer Symposium, Detroit, Michigan, April 13-14, 1989 |
| 264 | 1 | |a Boston, MA |b Springer US |c 1990 | |
| 300 | |a 1 Online-Ressource (XVI, 392 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Developments in Oncology |v 61 | |
| 520 | |a Over the past decade, techniques have been developed and implemented to observe metabolism noninvasively in localized regions of intact, living experimental animals and humans through the use of magnetic resonance spectroscopy (MRS). At the same time, magnetic resonance imaging (MRI) techniques developed in the 1970s and refined in this decade have been increasingly applied as a powerful clinical tool to probe human anatomy. Because of the unusual metabolic and physiologic characteristics of malignant tissues, oncology has been one of the primary focuses of the application of both MRS and MRI. Although considerable progress has been made in oncologic applications of magnetic resonance (MR), further research is needed to realize the full potential of MR in this area. Consequently, the 21st Annual Detroit Cancer Symposium entitled "Magnetic Resonance in Experimental and Clin ical Oncology" was organized to provide a forum for researchers in the field to report the state of the art of MRS and MRI in oncol ogy, to discuss future goals for MRS and MRI in oncology, and to define the research needed to meet those goals. The major emphasis of the symposium was on MRS due to both the recent widespread availability of clinical MRS instrumentation and the extensive amount of animal MRS research performed over the past half decade | ||
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Imaging / Radiology | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Radiology, Medical | |
| 650 | 0 | 7 | |a Kernspintomografie |0 (DE-588)4120806-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pathophysiologie |0 (DE-588)4044898-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a NMR-Spektroskopie |0 (DE-588)4075421-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |y 1989 |z Detroit Mich. |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Pathophysiologie |0 (DE-588)4044898-8 |D s |
| 689 | 0 | 2 | |a Kernspintomografie |0 (DE-588)4120806-7 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Pathophysiologie |0 (DE-588)4044898-8 |D s |
| 689 | 1 | 2 | |a NMR-Spektroskopie |0 (DE-588)4075421-2 |D s |
| 689 | 1 | |8 3\p |5 DE-604 | |
| 700 | 1 | |a Evelhoch, Jeffrey L. |4 edt | |
| 700 | 1 | |a Negendank, William |4 edt | |
| 700 | 1 | |a Valeriote, Frederick A. |4 edt | |
| 700 | 1 | |a Baker, Laurence H. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461280286 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792309352 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461306924 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4613-0691-7 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031525787 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/978-1-4613-0691-7 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180482483552256 |
|---|---|
| any_adam_object | |
| author2 | Evelhoch, Jeffrey L. Negendank, William Valeriote, Frederick A. Baker, Laurence H. |
| author2_role | edt edt edt edt |
| author2_variant | j l e jl jle w n wn f a v fa fav l h b lh lhb |
| author_facet | Evelhoch, Jeffrey L. Negendank, William Valeriote, Frederick A. Baker, Laurence H. |
| building | Verbundindex |
| bvnumber | BV046145602 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-1-4613-0691-7 (OCoLC)1119038745 (DE-599)BVBBV046145602 |
| dewey-full | 616.994 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994 |
| dewey-search | 616.994 |
| dewey-sort | 3616.994 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4613-0691-7 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04298nmm a2200685zcb4500</leader><controlfield tag="001">BV046145602</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1990 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461306917</subfield><subfield code="9">978-1-4613-0691-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4613-0691-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4613-0691-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119038745</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046145602</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Magnetic Resonance in Experimental and Clinical Oncology</subfield><subfield code="b">Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989</subfield><subfield code="c">edited by Jeffrey L. Evelhoch, William Negendank, Frederick A. Valeriote, Laurence H. Baker</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Proceedings of the 21st Annual Detroit Cancer Symposium, Detroit, Michigan, April 13-14, 1989</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XVI, 392 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Developments in Oncology</subfield><subfield code="v">61</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Over the past decade, techniques have been developed and implemented to observe metabolism noninvasively in localized regions of intact, living experimental animals and humans through the use of magnetic resonance spectroscopy (MRS). At the same time, magnetic resonance imaging (MRI) techniques developed in the 1970s and refined in this decade have been increasingly applied as a powerful clinical tool to probe human anatomy. Because of the unusual metabolic and physiologic characteristics of malignant tissues, oncology has been one of the primary focuses of the application of both MRS and MRI. Although considerable progress has been made in oncologic applications of magnetic resonance (MR), further research is needed to realize the full potential of MR in this area. Consequently, the 21st Annual Detroit Cancer Symposium entitled "Magnetic Resonance in Experimental and Clin ical Oncology" was organized to provide a forum for researchers in the field to report the state of the art of MRS and MRI in oncol ogy, to discuss future goals for MRS and MRI in oncology, and to define the research needed to meet those goals. The major emphasis of the symposium was on MRS due to both the recent widespread availability of clinical MRS instrumentation and the extensive amount of animal MRS research performed over the past half decade</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Imaging / Radiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radiology, Medical</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kernspintomografie</subfield><subfield code="0">(DE-588)4120806-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pathophysiologie</subfield><subfield code="0">(DE-588)4044898-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">NMR-Spektroskopie</subfield><subfield code="0">(DE-588)4075421-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1989</subfield><subfield code="z">Detroit Mich.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pathophysiologie</subfield><subfield code="0">(DE-588)4044898-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Kernspintomografie</subfield><subfield code="0">(DE-588)4120806-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pathophysiologie</subfield><subfield code="0">(DE-588)4044898-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">NMR-Spektroskopie</subfield><subfield code="0">(DE-588)4075421-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Evelhoch, Jeffrey L.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Negendank, William</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Valeriote, Frederick A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baker, Laurence H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461280286</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792309352</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461306924</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4613-0691-7</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031525787</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4613-0691-7</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift 1989 Detroit Mich. gnd-content |
| genre_facet | Konferenzschrift 1989 Detroit Mich. |
| id | DE-604.BV046145602 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:28Z |
| institution | BVB |
| isbn | 9781461306917 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031525787 |
| oclc_num | 1119038745 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XVI, 392 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1990 |
| publishDateSearch | 1990 |
| publishDateSort | 1990 |
| publisher | Springer US |
| record_format | marc |
| series2 | Developments in Oncology |
| spelling | Magnetic Resonance in Experimental and Clinical Oncology Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989 edited by Jeffrey L. Evelhoch, William Negendank, Frederick A. Valeriote, Laurence H. Baker Proceedings of the 21st Annual Detroit Cancer Symposium, Detroit, Michigan, April 13-14, 1989 Boston, MA Springer US 1990 1 Online-Ressource (XVI, 392 p) txt rdacontent c rdamedia cr rdacarrier Developments in Oncology 61 Over the past decade, techniques have been developed and implemented to observe metabolism noninvasively in localized regions of intact, living experimental animals and humans through the use of magnetic resonance spectroscopy (MRS). At the same time, magnetic resonance imaging (MRI) techniques developed in the 1970s and refined in this decade have been increasingly applied as a powerful clinical tool to probe human anatomy. Because of the unusual metabolic and physiologic characteristics of malignant tissues, oncology has been one of the primary focuses of the application of both MRS and MRI. Although considerable progress has been made in oncologic applications of magnetic resonance (MR), further research is needed to realize the full potential of MR in this area. Consequently, the 21st Annual Detroit Cancer Symposium entitled "Magnetic Resonance in Experimental and Clin ical Oncology" was organized to provide a forum for researchers in the field to report the state of the art of MRS and MRI in oncol ogy, to discuss future goals for MRS and MRI in oncology, and to define the research needed to meet those goals. The major emphasis of the symposium was on MRS due to both the recent widespread availability of clinical MRS instrumentation and the extensive amount of animal MRS research performed over the past half decade Oncology Imaging / Radiology Oncology Radiology, Medical Kernspintomografie (DE-588)4120806-7 gnd rswk-swf Pathophysiologie (DE-588)4044898-8 gnd rswk-swf NMR-Spektroskopie (DE-588)4075421-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift 1989 Detroit Mich. gnd-content Krebs Medizin (DE-588)4073781-0 s Pathophysiologie (DE-588)4044898-8 s Kernspintomografie (DE-588)4120806-7 s 2\p DE-604 NMR-Spektroskopie (DE-588)4075421-2 s 3\p DE-604 Evelhoch, Jeffrey L. edt Negendank, William edt Valeriote, Frederick A. edt Baker, Laurence H. edt Erscheint auch als Druck-Ausgabe 9781461280286 Erscheint auch als Druck-Ausgabe 9780792309352 Erscheint auch als Druck-Ausgabe 9781461306924 https://doi.org/10.1007/978-1-4613-0691-7 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Magnetic Resonance in Experimental and Clinical Oncology Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989 Oncology Imaging / Radiology Oncology Radiology, Medical Kernspintomografie (DE-588)4120806-7 gnd Pathophysiologie (DE-588)4044898-8 gnd NMR-Spektroskopie (DE-588)4075421-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4120806-7 (DE-588)4044898-8 (DE-588)4075421-2 (DE-588)4073781-0 (DE-588)1071861417 |
| title | Magnetic Resonance in Experimental and Clinical Oncology Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989 |
| title_alt | Proceedings of the 21st Annual Detroit Cancer Symposium, Detroit, Michigan, April 13-14, 1989 |
| title_auth | Magnetic Resonance in Experimental and Clinical Oncology Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989 |
| title_exact_search | Magnetic Resonance in Experimental and Clinical Oncology Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989 |
| title_full | Magnetic Resonance in Experimental and Clinical Oncology Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989 edited by Jeffrey L. Evelhoch, William Negendank, Frederick A. Valeriote, Laurence H. Baker |
| title_fullStr | Magnetic Resonance in Experimental and Clinical Oncology Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989 edited by Jeffrey L. Evelhoch, William Negendank, Frederick A. Valeriote, Laurence H. Baker |
| title_full_unstemmed | Magnetic Resonance in Experimental and Clinical Oncology Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989 edited by Jeffrey L. Evelhoch, William Negendank, Frederick A. Valeriote, Laurence H. Baker |
| title_short | Magnetic Resonance in Experimental and Clinical Oncology |
| title_sort | magnetic resonance in experimental and clinical oncology proceedings of the 21st annual detroit cancer symposium detroit michigan usa april 13 and 14 1989 |
| title_sub | Proceedings of the 21st Annual Detroit Cancer Symposium Detroit, Michigan, USA — April 13 and 14, 1989 |
| topic | Oncology Imaging / Radiology Oncology Radiology, Medical Kernspintomografie (DE-588)4120806-7 gnd Pathophysiologie (DE-588)4044898-8 gnd NMR-Spektroskopie (DE-588)4075421-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Oncology Imaging / Radiology Oncology Radiology, Medical Kernspintomografie Pathophysiologie NMR-Spektroskopie Krebs Medizin Konferenzschrift 1989 Detroit Mich. |
| url | https://doi.org/10.1007/978-1-4613-0691-7 |
| work_keys_str_mv | AT evelhochjeffreyl magneticresonanceinexperimentalandclinicaloncologyproceedingsofthe21stannualdetroitcancersymposiumdetroitmichiganusaapril13and141989 AT negendankwilliam magneticresonanceinexperimentalandclinicaloncologyproceedingsofthe21stannualdetroitcancersymposiumdetroitmichiganusaapril13and141989 AT valeriotefredericka magneticresonanceinexperimentalandclinicaloncologyproceedingsofthe21stannualdetroitcancersymposiumdetroitmichiganusaapril13and141989 AT bakerlaurenceh magneticresonanceinexperimentalandclinicaloncologyproceedingsofthe21stannualdetroitcancersymposiumdetroitmichiganusaapril13and141989 AT evelhochjeffreyl proceedingsofthe21stannualdetroitcancersymposiumdetroitmichiganapril13141989 AT negendankwilliam proceedingsofthe21stannualdetroitcancersymposiumdetroitmichiganapril13141989 AT valeriotefredericka proceedingsofthe21stannualdetroitcancersymposiumdetroitmichiganapril13141989 AT bakerlaurenceh proceedingsofthe21stannualdetroitcancersymposiumdetroitmichiganapril13141989 |